Search Results
Mar 24, 2026, 07:00 ET Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer
SAN DIEGO, March 24, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of in vitro diagnostics, is pleased to announce the appointment of Nathaniel "Nate" Sisitsky as its
More news about: QuidelOrtho Corporation
Feb 19, 2026, 09:17 ET Faster Cardiac Answers with High‑Sensitivity Troponin
SAN DIEGO, Feb. 19, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, has released episode 56 of its Science Bytes podcast, featuring Dr. Lindy Carlstrom, Global Medical
More news about: QuidelOrtho Corporation
Feb 18, 2026, 16:05 ET QuidelOrtho to Present at the 47th Annual Raymond James Institutional Investor Conference
SAN DIEGO, Feb. 18, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of innovative in vitro diagnostics, today announced that members of its management team will present
More news about: QuidelOrtho Corporation
Feb 16, 2026, 04:48 ET QuidelOrtho firma un acuerdo estratégico de suministro para ampliar su cartera mundial de inmunoensayos
más amplios y opciones de sistemas flexibles.Fuente: QuidelOrtho CorporationAcerca de QuidelOrthoQuidelOrtho (Nasdaq: QDEL) es líder mundial en soluciones diagnósticas, con experiencia en química clínica, inmunoensayos, inmunohematología y diagnóstico molecular. La empresa
More news about: QuidelOrtho Corporation
Feb 16, 2026, 03:42 ET QuidelOrtho firma un acuerdo de suministro estratégico para ampliar su cartera global de inmunoensayos
de productos y opciones de sistemas flexibles.Emisor: QuidelOrtho CorporationAcerca de QuidelOrthoQuidelOrtho (Nasdaq: QDEL) es líder mundial en soluciones de diagnóstico, con experiencia en química clínica, inmunoensayo, inmunohematología y diagnóstico molecular. La compañía
More news about: QuidelOrtho Corporation
Feb 16, 2026, 01:00 ET QuidelOrtho Enters Strategic Supply Agreement to Expand Global Immunoassay Portfolio
seeking broader menus and flexible system options.Source: QuidelOrtho CorporationAbout QuidelOrthoQuidelOrtho (Nasdaq: QDEL) is a global leader in diagnostic solutions, with expertise in clinical chemistry, immunoassay, immunohematology, and molecular diagnostics. The company
More news about: QuidelOrtho Corporation
Feb 16, 2026, 01:00 ET QuidelOrtho geht strategische Liefervereinbarung zur Erweiterung des globalen Immunoassay-Portfolios ein
Immunoassay-Lösungen bereitzustellen.Quelle: QuidelOrtho CorporationInformationen zu QuidelOrthoQuidelOrtho (Nasdaq: QDEL) ist ein weltweit führendes Unternehmen für diagnostische Lösungen mit Fachwissen in den Bereichen klinische Chemie, Immunoassays, Immunhämatologie sowie
More news about: QuidelOrtho Corporation
Feb 16, 2026, 01:00 ET QuidelOrtho Enters Strategic Supply Agreement to Expand Global Immunoassay Portfolio
seeking broader menus and flexible system options.Source: QuidelOrtho CorporationAbout QuidelOrthoQuidelOrtho (Nasdaq: QDEL) is a global leader in diagnostic solutions, with expertise in clinical chemistry, immunoassay, immunohematology, and molecular diagnostics. The company
More news about: QuidelOrtho Corporation
Feb 16, 2026, 01:00 ET QuidelOrtho conclut un accord d'approvisionnement stratégique pour élargir son portefeuille mondial d'immunoessais
larges et d'options de systèmes flexibles.Source : QuidelOrtho CorporationÀ propos de QuidelOrthoQuidelOrtho (Nasdaq : QDEL) est un leader mondial dans le domaine des solutions de diagnostic, avec une expertise en chimie clinique, en immunoessais, en immunohématologie et en
More news about: QuidelOrtho Corporation
Feb 11, 2026, 16:05 ET QuidelOrtho Reports Fourth Quarter and Full-Year 2025 Financial Results
―SAN DIEGO, Feb. 11, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of innovative in vitro diagnostics, today announced financial results for the fourth quarter and full-year
More news about: QuidelOrtho Corporation
Feb 03, 2026, 07:12 ET QuidelOrtho Receives Excellence Services Label in EMEA and Two Stevie® Awards
YearSAN DIEGO, Feb. 3, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho") received the Excellence Services Label for its Customer and Technical Services in EMEA, awarded by the independent association Esprit
More news about: QuidelOrtho Corporation
Jan 22, 2026, 07:12 ET Strengthening the blood supply: Awareness, challenges and donor impact
SAN DIEGO, Jan. 22, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released episode 55 of its Science Bytes podcast, featuring Michelle Mullens, Global Portfolio
More news about: QuidelOrtho Corporation
Jan 21, 2026, 07:00 ET QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results
SAN DIEGO, Jan. 21, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of in vitro diagnostics, announced today that it will report its financial results for the fourth
More news about: QuidelOrtho Corporation
Dec 18, 2025, 09:17 ET Innovating Diagnostics and What's Next
SAN DIEGO, Dec. 18, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released
More news about: QuidelOrtho Corporation
Nov 24, 2025, 07:00 ET QuidelOrtho To Participate In Upcoming Investor Conferences
SAN DIEGO, Nov. 24, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a global leader of in vitro diagnostics, announced today that members of its management team will participate in two upcoming investor
More news about: QuidelOrtho Corporation
Nov 20, 2025, 09:00 ET The Power of Prevention: Detecting Diabetes Before It Strikes
SAN DIEGO, Nov. 20, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released Episode 53 of its Science Bytes podcast, featuring Qian Ding, MD, PhD, Senior Medical
More news about: QuidelOrtho Corporation
Nov 13, 2025, 10:16 ET Commercial Display Market to Reach $92.3 billion, Globally, by 2034 at 6.2% CAGR: Allied Market Research
for compact AR applications. Emerging displays like Quantum Dot Electroluminescent (QDEL) and MicroLED offer superior brightness, color accuracy, and efficiency. QDEL enhances color with self-emissive pixels, while MicroLED supports fast modulation for AR/VR.
More news about: Allied Market Research
Nov 05, 2025, 16:05 ET QuidelOrtho Reports Third Quarter 2025 Financial Results
SAN DIEGO, Nov. 5, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of innovative in vitro diagnostics, today announced financial results for the third quarter ended
More news about: QuidelOrtho Corporation
Nov 03, 2025, 07:00 ET QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay
Nov. 3, 2025 /PRNewswire/ -- The U.S. Food and Drug Administration ("FDA") has granted QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a global leader of in vitro diagnostics, 510(k) clearance for the VITROS hs Troponin I Reagent Pack (the "VITROS hs Troponin I Assay").
More news about: QuidelOrtho Corporation
Oct 23, 2025, 18:45 ET Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics
SAN DIEGO, Oct. 23, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released Episode 52 of its Science Bytes podcast, featuring George Wierschem, MBA, MT(ASCP), Senior
More news about: QuidelOrtho Corporation
Oct 22, 2025, 07:00 ET QuidelOrtho to Report Third Quarter 2025 Financial Results
SAN DIEGO, Oct. 22, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of in vitro diagnostics, announced today that it will report its financial results for the third quarter
More news about: QuidelOrtho Corporation
Oct 16, 2025, 20:30 ET QuidelOrtho Showcases Leadership in Transfusion Medicine at AABB 2025
SAN DIEGO, Oct. 16, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, will highlight its ongoing commitment to transfusion medicine excellence at the Association for the Advancement
More news about: QuidelOrtho Corporation
Sep 25, 2025, 09:00 ET Through Shades of Illness: Science Bytes Podcast Discusses Why Testing Matters
DIEGO, Sept. 25, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, has released the latest episode of its Science Bytes podcast, featuring Dr. Terry
More news about: QuidelOrtho Corporation
Sep 22, 2025, 07:00 ET QuidelOrtho Announces Availability of QUICKVUE™ Influenza + SARS Test for Professional Use
Sept. 22, 2025 /PRNewswire/ -- Building on its leadership in point-of-care diagnostic testing, QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a leading global provider of innovative in vitro diagnostic technologies, is expanding its QUICKVUE portfolio with the QUICKVUE Influenza
More news about: QuidelOrtho Corporation
Aug 28, 2025, 07:30 ET QuidelOrtho to Participate in the Baird 2025 Global Healthcare Conference
DIEGO, Aug. 28, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs
More news about: QuidelOrtho Corporation